KRT19 and neoplasm: Immunohistochemistry revealed tumor marker patterns characteristic of malignancy, including parafibromin and E-cadherin loss and positivity for markers such as galectin-3 and cyclin D1 in parathyroid cancers and TTF1 and CK19 in thyroid cancer.